Pathkey.AI Ltd Lands First Paying Customer Before Chipforge Launch

Pathkey AI's Chipforge subsidiary has signed its first commercial contract — a US$50,000 FPGA design engagement with an Australian industrial automation company — ahead of the platform's general release, pulling forward the commercialisation timeline.
By Josua Ferreira -
  • Chipforge Pte. Ltd., the wholly owned subsidiary of ASX-listed Pathkey.AI (PKY), has signed its first commercial contract — a US$50,000 fixed-fee engagement with an Australian industrial automation company — ahead of the platform's general release.
  • The ten-week program is structured across two milestones, with 40% of the fee payable on Phase A acceptance and 60% on Phase B acceptance, tying the majority of revenue to a live FPGA demonstration against agreed success criteria.
  • Demand arriving before general platform launch brings forward Chipforge's commercialisation timeline, which management frames as a positive signal on product-market fit in the industrial enterprise segment across Asia Pacific.
  • Pathkey.AI now has both of its AI platforms generating commercial revenue, with TrialKey having secured a services agreement with Imunexus Therapeutics worth up to A$100,000 in April 2026.
  • The company has explicitly positioned this contract as the first of multiple regional commercial engagements, with the Chipforge Platform's general release still ahead of this agreement.

Chipforge lands first paying customer ahead of platform launch

Pathkey.AI Ltd (ASX: PKY) has confirmed that its wholly owned subsidiary Chipforge Pte. Ltd. signed its first commercial contract, ahead of the general release of the Chipforge Platform, bringing forward its commercialisation timeline.

The engagement is a paid proof of value to design and demonstrate the “intelligence unit” at the centre of an Australian industrial automation company’s automated cleaning and condition monitoring system. It marks the first external customer revenue from the platform, validating demand before launch.

The contract carries a US$50,000 fixed fee across a ten-week program structured in two phases.

Inside the contract: what Chipforge is delivering

The engagement scope

Under the agreement, Chipforge is designing real-time object recognition, automated decision logic and deterministic control for the customer’s automated system. The work is delivered end-to-end on an FPGA board, with the customer’s mechanical system emulated.

Scope covers the intelligence unit, its interfaces and its documentation. The mechanical equipment, field deployment, production manufacture and the operator application sit with the customer and their integration partners.

Commercial terms table

The material terms disclosed in Annexure A are summarised below.

Item Terms
Parties Chipforge Pte. Ltd. and the customer, an Australian industrial automation company
Fee US$50,000 fixed for the full 10-week engagement
Phase A (Milestone 1) Use Case Definition, System Architecture Document and Interface Control Document; anticipated August 2026
Phase B (Milestone 2) Design, verification and demonstration on FPGA, with readout against agreed success criteria; anticipated to be completed in Q2 2026
Payment 40% on Phase A acceptance, 60% on Phase B acceptance

Key points to note on the commercial structure:

  • Revenue will be recognised in accordance with the Group’s accounting policies as milestones are accepted.

Chipforge Contract Structure & Milestones

  • The contract is not of itself financially material to the Group. It is reported for its commercial significance as the first customer engagement for Chipforge.

CEO on proving the flow before launch

Andrew Farnsworth, CEO

“We set out to prove the flow on a real customer product before general release, and this Contract does exactly that. The customer is paying for design work that lands on hardware, with a delivery date attached. We structured the second milestone to be earned on results, because that is the standard we want to be held to and we are confident we will meet it. This is the first of the commercial engagements we are building across the region.”

What is AI-native chip design? (Educational section)

Chip design, spanning both FPGA and ASIC targets, is traditionally a slow process that requires specialist in-house engineering teams. Chipforge’s proposition is that an AI native design flow “shortens the path from design intent to verified silicon.”

For investors, the relevance lies in the target market. Automating this flow addresses customers who need custom hardware but carry no dedicated chip design team, a segment the company describes as underserved.

Why this matters for the investment case

The engagement confirms Chipforge’s target vertical: industrial enterprise firms across Asia Pacific that require custom hardware for a specific product without an in-house chip design team. The company regards this engagement as representative of that segment, not an isolated case.

Demand arrived ahead of general release, bringing forward the commercialisation timeline, which the company frames as a positive signal on product-market fit. Within the parent, Chipforge is one of two AI platforms, alongside TrialKey, which is focused on clinical trial design and optimisation.

The TrialKey platform secured its largest commercial engagement in April 2026, a services agreement with Imunexus Therapeutics valued at up to A$100,000, spanning clinical trial design, probability-of-success assessment, and investor communications workflows.

The investment takeaways can be summarised as follows:

  1. First revenue de-risks the commercialisation story.
  2. The fixed-scope, results-based milestone structure signals delivery confidence.
  3. The engagement represents a repeatable model for a targeted regional segment.

What comes next

Phase A deliverables, including the System Architecture Document and Interface Control Documentation, are anticipated in August 2026.

Phase B is expected to complete in Q2 2026, closing with a recorded end-to-end demonstration and a documented handover package. The company positions the contract as the first of multiple regional commercial engagements Chipforge is building, with the platform’s general release still ahead of this agreement.

Don’t Miss the Next ASX Tech Winner

Big News Blast delivers FREE breaking ASX tech news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button at StockWire X to get started today.

 

Frequently Asked Questions

What is the Chipforge Platform and what does it do?

Chipforge is an AI-native chip design platform developed by Pathkey.AI subsidiary Chipforge Pte. Ltd. that shortens the path from design intent to verified silicon, targeting industrial enterprise customers who need custom FPGA or ASIC hardware but have no in-house chip design team.

What are the terms of Chipforge's first commercial contract?

The contract is a US$50,000 fixed-fee, ten-week proof-of-value engagement with an Australian industrial automation company, structured across two milestones — Phase A covering system architecture documentation and Phase B covering FPGA design, verification, and live demonstration — with payment split 40% and 60% on acceptance of each phase.

What is Pathkey AI (ASX: PKY) and what platforms does it operate?

Pathkey.AI Ltd (ASX: PKY) is an ASX-listed technology company operating two AI platforms: Chipforge, focused on AI-native chip design for industrial enterprise customers, and TrialKey, focused on clinical trial design and optimisation for pharmaceutical companies.

Why did Chipforge sign a commercial contract before its platform officially launched?

According to CEO Andrew Farnsworth, Chipforge deliberately sought to prove its design flow on a real customer product before general release, using the engagement to validate the platform on live hardware with a delivery date attached rather than waiting for a formal launch.

What comes next for Chipforge after this first contract?

Phase A deliverables — including the System Architecture Document and Interface Control Documentation — are anticipated in August 2026, with Phase B expected to close with a recorded end-to-end FPGA demonstration; the company has also indicated this is the first of multiple commercial engagements it is building across the Asia Pacific region.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher